Also trades as: LABB.MX (MEX) · $vol 2M

$0.73

+0.04 (+6.51%)

Weekly Expected Move ±6.6%

$1 $1 $1 $1 $1

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · $713.4M mcap · 671M float · 0.0012% daily turnover · Short 68% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$973M +9.0% ▲

5Y CAGR: +6.9%

Gross Profit

$611M +6.8% ▲

5Y CAGR: +7.2%

Operating Income

$207M +10.0% ▲

5Y CAGR: +7.0%

Net Income

$89M -94.0% ▼

5Y CAGR: +4.8%

EPS (Diluted)

$0.09 -94.0% ▼

5Y CAGR: +5.6%

EBITDA

$228M -94.5% ▼

5Y CAGR: +10.2%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$754M	$862M	$969M	$892M	$973M
YoY Growth	+8.3%	+14.4%	+12.4%	-7.9%	+9.0%
Cost of Revenue	$288M	$341M	$376M	$6.7B	$362M
Gross Profit	$466M	$521M	$594M	$572M	$611M
Gross Margin	61.7%	60.4%	61.2%	64.1%	62.8%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$320M	$355M	$405M	$386M	$404M
Operating Expenses	$320M	$352M	$405M	$384M	$404M
Operating Income	$146M	$169M	$189M	$188M	$207M
Operating Margin	19.4%	19.6%	19.5%	21.1%	21.3%
Interest Expense	$22M	$27M	$830M	$888M	$58M
Income Before Tax	$1.4B	$115M	$1.7B	$139M	$135M
Tax Expense	$45M	$44M	$636M	$38M	$46M
Net Income	$64M	$71M	$64M	$1.5B	$89M
Net Margin	8.4%	8.3%	6.6%	167.3%	9.2%
EPS (Diluted)	$0.06	$0.07	$0.07	$1.53	$0.09
EBITDA	$143M	$153M	$167M	$4.1B	$228M
Shares Outstanding	1.01B	993M	957M	978M	974M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$5.1B	$4.7B	$4.4B	$249M	$4.5B	$4.0B	$4.2B	$4.4B
Cost of Revenue	$1.8B	$1.7B	$1.6B	$91M	$1.6B	$1.6B	$1.5B	$1.6B
Gross Profit	$3.3B	$2.9B	$2.8B	$158M	$2.8B	$2.4B	$2.6B	$2.8B
Gross Margin	64.3%	63.1%	62.8%	63.5%	63.8%	61.0%	63.4%	64.6%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$2.1B	$1.8B	$1.7B	$1.9B	$1.9B	$1.6B	$1.7B	$1.9B
Operating Expenses	$2.1B	$1.9B	$1.8B	$103M	$1.9B	$1.6B	$1.8B	$2.0B
Operating Income	$1.1B	$1.0B	$961M	$55M	$909M	$860M	$870M	$873M
Operating Margin	22.2%	21.7%	21.8%	22.0%	20.4%	21.4%	20.8%	19.9%
Interest Expense	$230M	$248M	$220M	$194M	$268M	$253M	$285M	$278M
Income Before Tax	$932M	$599M	$701M	$30M	$610M	$567M	$642M	$535M
Tax Expense	$272M	$126M	$202M	$11M	$174M	$248M	$149M	$160M
Net Income	$33M	$473M	$499M	$19M	$436M	$319M	$493M	$374M
Net Margin	0.7%	10.1%	11.3%	7.6%	9.8%	8.0%	11.8%	8.5%
EPS (Diluted)	$0.04	$0.48	$0.51	$0.02	$0.02	$0.33	$0.51	$0.37
EBITDA	$1.3B	$969M	$1.0B	$843M	$974M	$1.1B	$961M	$802M
Shares Outstanding	945M	978M	974M	974M	977M	969M	975M	1.01B

GNMLF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet